Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy-Reference-Cited by-同舟云学术

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy

Published:2023-09-27 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Martinez-Morilla Sandra¹,Moutafi Myrto¹,Fernandez Aileen I.¹,Jessel Shlomit²,Divakar Prajan³,Wong Pok Fai¹,Garcia-Milian Rolando⁴,Schalper Kurt A.¹,Kluger Harriet M.²,Rimm David L.¹²

Affiliation:

1. Department of Pathology, Yale School of Medicine, New Haven, CT, USA

2. Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA

3. NanoString Technologies, Seattle, WA, USA

4. Bioinformatics Support Program, Cushing/Whitney Medical Library, Yale School of Medicine, New Haven, CT, USA

Funder

Navigate Biopharma

Yale SPORE in Skin Cancer

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2260618

Reference41 articles.

1. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

3. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

4. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

5. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of resistance and response to melanoma therapy;Nature Cancer;2024-07-17

2. Non-electrophysiological techniques targeting transient receptor potential (TRP) gene of gastrointestinal tract;International Journal of Biological Macromolecules;2024-03

3. Multiplex protein imaging in tumour biology;Nature Reviews Cancer;2024-02-05